 | • レポートコード：GIR-2104Z03270 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、クロストリジウム・ディフィシル治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。クロストリジウム・ディフィシル治療の種類別市場規模（狭域スペクトル抗生物質、広域スペクトル抗生物質）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・クロストリジウム・ディフィシル治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Actelion Pharmaceuticals、Merck、Pfizer、Summit Therapeutics、Astellas Pharma、CRESTOVO、Da Volterra、Immuron、MGB Biopharma、Novartis、Otsuka Pharmaceutical、Rebiotix、Romark Laboratories、Sanofi Pasteur、Seres Therapeutics、Takeda、Synthetic Biologics、Bausch Health、Valneva ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：狭域スペクトル抗生物質、広域スペクトル抗生物質 ・用途別分析2016年-2026年：病院、診療所、その他 ・クロストリジウム・ディフィシル治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・クロストリジウム・ディフィシル治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・クロストリジウム・ディフィシル治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・クロストリジウム・ディフィシル治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・クロストリジウム・ディフィシル治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Clostridium Difficile Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Clostridium Difficile Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Clostridium Difficile Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Clostridium Difficile Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Narrow Spectrum?Antibiotics
Broad Spectrum Antibiotics
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
Actelion Pharmaceuticals
Merck
Pfizer
Summit Therapeutics
Astellas Pharma
CRESTOVO
Da Volterra
Immuron
MGB Biopharma
Novartis
Otsuka Pharmaceutical
Rebiotix
Romark Laboratories
Sanofi Pasteur
Seres Therapeutics
Takeda
Synthetic Biologics
Bausch Health
Valneva
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Clostridium Difficile Treatment
1.2 Classification of Clostridium Difficile Treatment by Type
1.2.1 Overview: Global Clostridium Difficile Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Clostridium Difficile Treatment Revenue Market Share by Type in 2020
1.2.3 Narrow Spectrum?Antibiotics
1.2.4 Broad Spectrum Antibiotics
1.3 Global Clostridium Difficile Treatment Market by Application
1.3.1 Overview: Global Clostridium Difficile Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Clostridium Difficile Treatment Market Size & Forecast
1.5 Global Clostridium Difficile Treatment Market Size and Forecast by Region
1.5.1 Global Clostridium Difficile Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Clostridium Difficile Treatment Market Size by Region, (2016-2021)
1.5.3 North America Clostridium Difficile Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Clostridium Difficile Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Clostridium Difficile Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Clostridium Difficile Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Clostridium Difficile Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Clostridium Difficile Treatment Market Drivers
1.6.2 Clostridium Difficile Treatment Market Restraints
1.6.3 Clostridium Difficile Treatment Trends Analysis
2 Company Profiles
2.1 Actelion Pharmaceuticals
2.1.1 Actelion Pharmaceuticals Details
2.1.2 Actelion Pharmaceuticals Major Business
2.1.3 Actelion Pharmaceuticals Clostridium Difficile Treatment Product and Solutions
2.1.4 Actelion Pharmaceuticals Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Actelion Pharmaceuticals Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Clostridium Difficile Treatment Product and Solutions
2.2.4 Merck Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Clostridium Difficile Treatment Product and Solutions
2.3.4 Pfizer Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Summit Therapeutics
2.4.1 Summit Therapeutics Details
2.4.2 Summit Therapeutics Major Business
2.4.3 Summit Therapeutics Clostridium Difficile Treatment Product and Solutions
2.4.4 Summit Therapeutics Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Summit Therapeutics Recent Developments and Future Plans
2.5 Astellas Pharma
2.5.1 Astellas Pharma Details
2.5.2 Astellas Pharma Major Business
2.5.3 Astellas Pharma Clostridium Difficile Treatment Product and Solutions
2.5.4 Astellas Pharma Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Astellas Pharma Recent Developments and Future Plans
2.6 CRESTOVO
2.6.1 CRESTOVO Details
2.6.2 CRESTOVO Major Business
2.6.3 CRESTOVO Clostridium Difficile Treatment Product and Solutions
2.6.4 CRESTOVO Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 CRESTOVO Recent Developments and Future Plans
2.7 Da Volterra
2.7.1 Da Volterra Details
2.7.2 Da Volterra Major Business
2.7.3 Da Volterra Clostridium Difficile Treatment Product and Solutions
2.7.4 Da Volterra Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Da Volterra Recent Developments and Future Plans
2.8 Immuron
2.8.1 Immuron Details
2.8.2 Immuron Major Business
2.8.3 Immuron Clostridium Difficile Treatment Product and Solutions
2.8.4 Immuron Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Immuron Recent Developments and Future Plans
2.9 MGB Biopharma
2.9.1 MGB Biopharma Details
2.9.2 MGB Biopharma Major Business
2.9.3 MGB Biopharma Clostridium Difficile Treatment Product and Solutions
2.9.4 MGB Biopharma Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 MGB Biopharma Recent Developments and Future Plans
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Clostridium Difficile Treatment Product and Solutions
2.10.4 Novartis Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Novartis Recent Developments and Future Plans
2.11 Otsuka Pharmaceutical
2.11.1 Otsuka Pharmaceutical Details
2.11.2 Otsuka Pharmaceutical Major Business
2.11.3 Otsuka Pharmaceutical Clostridium Difficile Treatment Product and Solutions
2.11.4 Otsuka Pharmaceutical Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Otsuka Pharmaceutical Recent Developments and Future Plans
2.12 Rebiotix
2.12.1 Rebiotix Details
2.12.2 Rebiotix Major Business
2.12.3 Rebiotix Clostridium Difficile Treatment Product and Solutions
2.12.4 Rebiotix Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Rebiotix Recent Developments and Future Plans
2.13 Romark Laboratories
2.13.1 Romark Laboratories Details
2.13.2 Romark Laboratories Major Business
2.13.3 Romark Laboratories Clostridium Difficile Treatment Product and Solutions
2.13.4 Romark Laboratories Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Romark Laboratories Recent Developments and Future Plans
2.14 Sanofi Pasteur
2.14.1 Sanofi Pasteur Details
2.14.2 Sanofi Pasteur Major Business
2.14.3 Sanofi Pasteur Clostridium Difficile Treatment Product and Solutions
2.14.4 Sanofi Pasteur Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Sanofi Pasteur Recent Developments and Future Plans
2.15 Seres Therapeutics
2.15.1 Seres Therapeutics Details
2.15.2 Seres Therapeutics Major Business
2.15.3 Seres Therapeutics Clostridium Difficile Treatment Product and Solutions
2.15.4 Seres Therapeutics Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Seres Therapeutics Recent Developments and Future Plans
2.16 Takeda
2.16.1 Takeda Details
2.16.2 Takeda Major Business
2.16.3 Takeda Clostridium Difficile Treatment Product and Solutions
2.16.4 Takeda Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Takeda Recent Developments and Future Plans
2.17 Synthetic Biologics
2.17.1 Synthetic Biologics Details
2.17.2 Synthetic Biologics Major Business
2.17.3 Synthetic Biologics Clostridium Difficile Treatment Product and Solutions
2.17.4 Synthetic Biologics Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Synthetic Biologics Recent Developments and Future Plans
2.18 Bausch Health
2.18.1 Bausch Health Details
2.18.2 Bausch Health Major Business
2.18.3 Bausch Health Clostridium Difficile Treatment Product and Solutions
2.18.4 Bausch Health Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Bausch Health Recent Developments and Future Plans
2.19 Valneva
2.19.1 Valneva Details
2.19.2 Valneva Major Business
2.19.3 Valneva Clostridium Difficile Treatment Product and Solutions
2.19.4 Valneva Clostridium Difficile Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Valneva Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Clostridium Difficile Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Clostridium Difficile Treatment Players Market Share
3.2.2 Top 10 Clostridium Difficile Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Clostridium Difficile Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Clostridium Difficile Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Clostridium Difficile Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Clostridium Difficile Treatment Revenue Market Share by Application (2016-2021)
5.2 Clostridium Difficile Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Clostridium Difficile Treatment Revenue by Type (2016-2026)
6.2 North America Clostridium Difficile Treatment Revenue by Application (2016-2026)
6.3 North America Clostridium Difficile Treatment Market Size by Country
6.3.1 North America Clostridium Difficile Treatment Revenue by Country (2016-2026)
6.3.2 United States Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Clostridium Difficile Treatment Revenue by Type (2016-2026)
7.2 Europe Clostridium Difficile Treatment Revenue by Application (2016-2026)
7.3 Europe Clostridium Difficile Treatment Market Size by Country
7.3.1 Europe Clostridium Difficile Treatment Revenue by Country (2016-2026)
7.3.2 Germany Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
7.3.3 France Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Clostridium Difficile Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Clostridium Difficile Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Clostridium Difficile Treatment Market Size by Region
8.3.1 Asia-Pacific Clostridium Difficile Treatment Revenue by Region (2016-2026)
8.3.2 China Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
8.3.5 India Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Clostridium Difficile Treatment Revenue by Type (2016-2026)
9.2 South America Clostridium Difficile Treatment Revenue by Application (2016-2026)
9.3 South America Clostridium Difficile Treatment Market Size by Country
9.3.1 South America Clostridium Difficile Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Clostridium Difficile Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Clostridium Difficile Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Clostridium Difficile Treatment Market Size by Country
10.3.1 Middle East & Africa Clostridium Difficile Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Clostridium Difficile Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Clostridium Difficile Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Clostridium Difficile Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Clostridium Difficile Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Clostridium Difficile Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Clostridium Difficile Treatment Revenue Market Share by Region (2021-2026)
Table 6. Actelion Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Actelion Pharmaceuticals Major Business
Table 8. Actelion Pharmaceuticals Clostridium Difficile Treatment Product and Solutions
Table 9. Actelion Pharmaceuticals Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Clostridium Difficile Treatment Product and Solutions
Table 13. Merck Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Clostridium Difficile Treatment Product and Solutions
Table 17. Pfizer Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Summit Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. Summit Therapeutics Major Business
Table 20. Summit Therapeutics Clostridium Difficile Treatment Product and Solutions
Table 21. Summit Therapeutics Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 23. Astellas Pharma Major Business
Table 24. Astellas Pharma Clostridium Difficile Treatment Product and Solutions
Table 25. Astellas Pharma Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. CRESTOVO Corporate Information, Head Office, and Major Competitors
Table 27. CRESTOVO Major Business
Table 28. CRESTOVO Clostridium Difficile Treatment Product and Solutions
Table 29. CRESTOVO Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Da Volterra Corporate Information, Head Office, and Major Competitors
Table 31. Da Volterra Major Business
Table 32. Da Volterra Clostridium Difficile Treatment Product and Solutions
Table 33. Da Volterra Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Immuron Corporate Information, Head Office, and Major Competitors
Table 35. Immuron Major Business
Table 36. Immuron Clostridium Difficile Treatment Product and Solutions
Table 37. Immuron Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. MGB Biopharma Corporate Information, Head Office, and Major Competitors
Table 39. MGB Biopharma Major Business
Table 40. MGB Biopharma Clostridium Difficile Treatment Product and Solutions
Table 41. MGB Biopharma Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Novartis Corporate Information, Head Office, and Major Competitors
Table 43. Novartis Major Business
Table 44. Novartis Clostridium Difficile Treatment Product and Solutions
Table 45. Novartis Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Otsuka Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. Otsuka Pharmaceutical Major Business
Table 48. Otsuka Pharmaceutical Clostridium Difficile Treatment Product and Solutions
Table 49. Otsuka Pharmaceutical Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Rebiotix Corporate Information, Head Office, and Major Competitors
Table 51. Rebiotix Major Business
Table 52. Rebiotix Clostridium Difficile Treatment Product and Solutions
Table 53. Rebiotix Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Romark Laboratories Corporate Information, Head Office, and Major Competitors
Table 55. Romark Laboratories Major Business
Table 56. Romark Laboratories Clostridium Difficile Treatment Product and Solutions
Table 57. Romark Laboratories Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Sanofi Pasteur Corporate Information, Head Office, and Major Competitors
Table 59. Sanofi Pasteur Major Business
Table 60. Sanofi Pasteur Clostridium Difficile Treatment Product and Solutions
Table 61. Sanofi Pasteur Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Seres Therapeutics Corporate Information, Head Office, and Major Competitors
Table 63. Seres Therapeutics Major Business
Table 64. Seres Therapeutics Clostridium Difficile Treatment Product and Solutions
Table 65. Seres Therapeutics Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Takeda Corporate Information, Head Office, and Major Competitors
Table 67. Takeda Major Business
Table 68. Takeda Clostridium Difficile Treatment Product and Solutions
Table 69. Takeda Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Synthetic Biologics Corporate Information, Head Office, and Major Competitors
Table 71. Synthetic Biologics Major Business
Table 72. Synthetic Biologics Clostridium Difficile Treatment Product and Solutions
Table 73. Synthetic Biologics Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 75. Bausch Health Major Business
Table 76. Bausch Health Clostridium Difficile Treatment Product and Solutions
Table 77. Bausch Health Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Valneva Corporate Information, Head Office, and Major Competitors
Table 79. Valneva Major Business
Table 80. Valneva Clostridium Difficile Treatment Product and Solutions
Table 81. Valneva Clostridium Difficile Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Global Clostridium Difficile Treatment Revenue (USD Million) by Players (2019-2021)
Table 83. Global Clostridium Difficile Treatment Revenue Share by Players (2019-2021)
Table 84. Breakdown of Clostridium Difficile Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Clostridium Difficile Treatment Players Head Office, Products and Services Provided
Table 86. Clostridium Difficile Treatment Mergers & Acquisitions in the Past Five Years
Table 87. Clostridium Difficile Treatment New Entrants and Expansion Plans
Table 88. Global Clostridium Difficile Treatment Revenue (USD Million) by Type (2016-2021)
Table 89. Global Clostridium Difficile Treatment Revenue Share by Type (2016-2021)
Table 90. Global Clostridium Difficile Treatment Revenue Forecast by Type (2021-2026)
Table 91. Global Clostridium Difficile Treatment Revenue by Application (2016-2021)
Table 92. Global Clostridium Difficile Treatment Revenue Forecast by Application (2021-2026)
Table 93. North America Clostridium Difficile Treatment Revenue by Type (2016-2021) & (USD Million)
Table 94. North America Clostridium Difficile Treatment Revenue by Type (2021-2026) & (USD Million)
Table 95. North America Clostridium Difficile Treatment Revenue by Application (2016-2021) & (USD Million)
Table 96. North America Clostridium Difficile Treatment Revenue by Application (2021-2026) & (USD Million)
Table 97. North America Clostridium Difficile Treatment Revenue by Country (2016-2021) & (USD Million)
Table 98. North America Clostridium Difficile Treatment Revenue by Country (2021-2026) & (USD Million)
Table 99. Europe Clostridium Difficile Treatment Revenue by Type (2016-2021) & (USD Million)
Table 100. Europe Clostridium Difficile Treatment Revenue by Type (2021-2026) & (USD Million)
Table 101. Europe Clostridium Difficile Treatment Revenue by Application (2016-2021) & (USD Million)
Table 102. Europe Clostridium Difficile Treatment Revenue by Application (2021-2026) & (USD Million)
Table 103. Europe Clostridium Difficile Treatment Revenue by Country (2016-2021) & (USD Million)
Table 104. Europe Clostridium Difficile Treatment Revenue by Country (2021-2026) & (USD Million)
Table 105. Asia-Pacific Clostridium Difficile Treatment Revenue by Type (2016-2021) & (USD Million)
Table 106. Asia-Pacific Clostridium Difficile Treatment Revenue by Type (2021-2026) & (USD Million)
Table 107. Asia-Pacific Clostridium Difficile Treatment Revenue by Application (2016-2021) & (USD Million)
Table 108. Asia-Pacific Clostridium Difficile Treatment Revenue by Application (2021-2026) & (USD Million)
Table 109. Asia-Pacific Clostridium Difficile Treatment Revenue by Region (2016-2021) & (USD Million)
Table 110. Asia-Pacific Clostridium Difficile Treatment Revenue by Region (2021-2026) & (USD Million)
Table 111. South America Clostridium Difficile Treatment Revenue by Type (2016-2021) & (USD Million)
Table 112. South America Clostridium Difficile Treatment Revenue by Type (2021-2026) & (USD Million)
Table 113. South America Clostridium Difficile Treatment Revenue by Application (2016-2021) & (USD Million)
Table 114. South America Clostridium Difficile Treatment Revenue by Application (2021-2026) & (USD Million)
Table 115. South America Clostridium Difficile Treatment Revenue by Country (2016-2021) & (USD Million)
Table 116. South America Clostridium Difficile Treatment Revenue by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Clostridium Difficile Treatment Revenue by Type (2016-2021) & (USD Million)
Table 118. Middle East & Africa Clostridium Difficile Treatment Revenue by Type (2021-2026) & (USD Million)
Table 119. Middle East & Africa Clostridium Difficile Treatment Revenue by Application (2016-2021) & (USD Million)
Table 120. Middle East & Africa Clostridium Difficile Treatment Revenue by Application (2021-2026) & (USD Million)
Table 121. Middle East & Africa Clostridium Difficile Treatment Revenue by Country (2016-2021) & (USD Million)
Table 122. Middle East & Africa Clostridium Difficile Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Clostridium Difficile Treatment Picture
Figure 2. Global Clostridium Difficile Treatment Revenue Market Share by Type in 2020
Figure 3. Narrow Spectrum?Antibiotics
Figure 4. Broad Spectrum Antibiotics
Figure 5. Clostridium Difficile Treatment Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Others Picture
Figure 9. Global Clostridium Difficile Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Clostridium Difficile Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Clostridium Difficile Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Clostridium Difficile Treatment Revenue Market Share by Region in 2020
Figure 13. North America Clostridium Difficile Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Clostridium Difficile Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Clostridium Difficile Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Clostridium Difficile Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Clostridium Difficile Treatment Market Drivers
Figure 18. Clostridium Difficile Treatment Market Restraints
Figure 19. Clostridium Difficile Treatment Market Trends
Figure 20. Actelion Pharmaceuticals Recent Developments and Future Plans
Figure 21. Merck Recent Developments and Future Plans
Figure 22. Pfizer Recent Developments and Future Plans
Figure 23. Summit Therapeutics Recent Developments and Future Plans
Figure 24. Astellas Pharma Recent Developments and Future Plans
Figure 25. CRESTOVO Recent Developments and Future Plans
Figure 26. Da Volterra Recent Developments and Future Plans
Figure 27. Immuron Recent Developments and Future Plans
Figure 28. MGB Biopharma Recent Developments and Future Plans
Figure 29. Novartis Recent Developments and Future Plans
Figure 30. Otsuka Pharmaceutical Recent Developments and Future Plans
Figure 31. Rebiotix Recent Developments and Future Plans
Figure 32. Romark Laboratories Recent Developments and Future Plans
Figure 33. Sanofi Pasteur Recent Developments and Future Plans
Figure 34. Seres Therapeutics Recent Developments and Future Plans
Figure 35. Takeda Recent Developments and Future Plans
Figure 36. Synthetic Biologics Recent Developments and Future Plans
Figure 37. Bausch Health Recent Developments and Future Plans
Figure 38. Valneva Recent Developments and Future Plans
Figure 40. Global Clostridium Difficile Treatment Revenue Share by Players in 2020
Figure 41. Clostridium Difficile Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 42. Global Top 3 Players Clostridium Difficile Treatment Revenue Market Share in 2020
Figure 43. Global Top 10 Players Clostridium Difficile Treatment Revenue Market Share in 2020
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 45. Global Clostridium Difficile Treatment Revenue Share by Type in 2020
Figure 46. Global Clostridium Difficile Treatment Market Share Forecast by Type (2021-2026)
Figure 47. Global Clostridium Difficile Treatment Revenue Share by Application in 2020
Figure 48. Global Clostridium Difficile Treatment Market Share Forecast by Application (2021-2026)
Figure 49. North America Clostridium Difficile Treatment Sales Market Share by Type (2016-2026)
Figure 50. North America Clostridium Difficile Treatment Sales Market Share by Application (2016-2026)
Figure 51. North America Clostridium Difficile Treatment Revenue Market Share by Country (2016-2026)
Figure 52. United States Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Canada Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Mexico Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Europe Clostridium Difficile Treatment Sales Market Share by Type (2016-2026)
Figure 56. Europe Clostridium Difficile Treatment Sales Market Share by Application (2016-2026)
Figure 57. Europe Clostridium Difficile Treatment Revenue Market Share by Country (2016-2026)
Figure 58. Germany Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. France Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. United Kingdom Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Russia Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Italy Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Asia-Pacific Clostridium Difficile Treatment Sales Market Share by Type (2016-2026)
Figure 64. Asia-Pacific Clostridium Difficile Treatment Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Clostridium Difficile Treatment Revenue Market Share by Region (2016-2026)
Figure 66. China Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Japan Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South Korea Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. India Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Southeast Asia Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Australia Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South America Clostridium Difficile Treatment Sales Market Share by Type (2016-2026)
Figure 73. South America Clostridium Difficile Treatment Sales Market Share by Application (2016-2026)
Figure 74. South America Clostridium Difficile Treatment Revenue Market Share by Country (2016-2026)
Figure 75. Brazil Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Argentina Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Middle East and Africa Clostridium Difficile Treatment Sales Market Share by Type (2016-2026)
Figure 78. Middle East and Africa Clostridium Difficile Treatment Sales Market Share by Application (2016-2026)
Figure 79. Middle East and Africa Clostridium Difficile Treatment Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. UAE Clostridium Difficile Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界のクロストリジウム・ディフィシル治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Clostridium Difficile Treatment Market The global Clostridium Difficile Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 世界のクロストリジウム・ディフィシル感染症治療市場規模・現状・予測（2021年-2027年） Clostridium difficile is one of the most common hospital acquired infections and in the last decade, there has been a notable increase in the incidence of clostridium difficile infection as well as the severity of the infection owing to recurrence and antibiotic resistance. Disproportionately higher…
- 世界のクロストリジウム診断市場規模・現状・予測（2021年-2027年） Clostridium is a gram-positive bacteria that belongs to the Firmicutes phylum. There are multiple species of Clostridium — Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, and Clostridium sordellii, which are responsible for numerous infections. Clostridium …
- 世界のコラゲナーゼクロストリジウム ヒストリチクム市場 2021：企業別、地域別、種類・用途別 The Collagenase Clostridium Histolyticum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のクロストリジウムワクチン市場 2021：企業別、地域別、種類・用途別 The Clostridium Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…